Related Experiment Videos
Subfascial endoscopic perforator surgery for venous ulcers.
D W H Lee1, Y H Lam, A C W Chan
1Department of Surgery, North District Hospital, 9 Po Kin Road, Hong Kong.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|August 9, 2003
Summary
Subfascial endoscopic perforator surgery effectively treats severe chronic venous insufficiency and venous ulceration. This minimally invasive procedure demonstrated high ulcer healing rates and significant symptom improvement in patients with incompetent perforating veins.
Area of Science:
- Vascular Surgery
- Phlebology
- Minimally Invasive Procedures
Background:
- Severe chronic venous insufficiency (CVI) and persistent venous ulceration pose significant clinical challenges.
- Incompetent perforating veins in the calf are a common cause of advanced CVI and recalcitrant ulcers.
- Previous superficial venous ablative surgery may not fully address underlying perforator incompetence.
Purpose of the Study:
- To evaluate the safety and efficacy of subfascial endoscopic perforator surgery (SEPS) in patients with severe CVI and long-standing venous ulceration.
- To assess ulcer healing rates, recurrence, and clinical outcomes following SEPS.
- To determine the impact of SEPS on patient symptom and disability scores.
Main Methods:
- Retrospective analysis of 12 patients undergoing SEPS for severe CVI and venous ulceration.
- All patients had prior superficial venous ablative surgery and persistent ulcers (>10 years).
- Outcome measures included ulcer healing time, recurrence, clinical symptom scores, and disability scores.
Main Results:
- SEPS was associated with a single wound complication.
- Cumulative ulcer healing rates were 25% at 3 months, 42% at 6 months, and 92% at 1 year.
- Mean clinical and disability scores significantly improved (P<0.001) at a median follow-up of 15 months.
Conclusions:
- Subfascial endoscopic perforator surgery is a safe and effective treatment for severe CVI and venous ulceration due to incompetent calf perforators.
- SEPS offers a high rate of ulcer healing and substantial improvement in patient-reported outcomes.
- This approach is valuable for patients with persistent venous ulceration refractory to other treatments.